Advanced renal cell carcinoma: First results from the prospective research platform CARAT for patients with mRCC in Germany

Goebell P, Mueller L, Gruellich C, Reichert D, Boegemann M, Doerfel S, Von Der Heyde E, Binninger A, Jaenicke M, Merling M, Marschner NW, Staehler M, Gruenwald V (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Annals of Oncology Elsevier

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Conference Proceedings Title: ANNALS OF ONCOLOGY

Event location: Barcelona ES

DOI: 10.1093/annonc/mdz249.065

Authors with CRIS profile

Peter Goebell Urologische Klinik

Involved external institutions

iOMEDICO AG DE Germany (DE) Universitätsklinikum Münster DE Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden DE Germany (DE) Onkozentrum Dresden/Freiberg DE Germany (DE) Ludwig-Maximilians-Universität (LMU) DE Germany (DE) Universitätsklinikum Essen DE Germany (DE) Onkologie Leer - Emden - Papenburg DE Germany (DE)

How to cite

APA:

Goebell, P., Mueller, L., Gruellich, C., Reichert, D., Boegemann, M., Doerfel, S.,... Gruenwald, V. (2019). Advanced renal cell carcinoma: First results from the prospective research platform CARAT for patients with mRCC in Germany. In ANNALS OF ONCOLOGY. Barcelona, ES: OXFORD: OXFORD UNIV PRESS.

MLA:

Goebell, Peter, et al. "Advanced renal cell carcinoma: First results from the prospective research platform CARAT for patients with mRCC in Germany." Proceedings of the 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona OXFORD: OXFORD UNIV PRESS, 2019.

BibTeX: Download